Analyst Robert Marcus works at JPMORGAN and is covering the the Healthcare sector with 10 price targets and ratings documented since 2019 spanning on 1 stocks.
Robert Marcus's average stock forecast success ratio is 40% with an average time for price targets to be met of 135 days.
Most recent stock forecast was given on PEN, Penumbra, Inc at 23-Feb-2022.
Analyst best performing recommendations are on PEN (PENUMBRA, INC).
The best stock recommendation documented was for PEN (PENUMBRA, INC) at 5/30/2019. The price target of $170 was fulfilled within 41 days with a profit of $23.7 (16.2%) receiving and performance score of 3.95.
Average potential price target upside
Currently, out of the existing stock ratings of Robert Marcus - 9 which are a Hold (20%), 36 which are a Buy (80%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
350
$43.5 (14.19%)
284
12 days ago
6/8 (75%)
$45.91 (20.38%)
165
Buy
325
$18.5 (6.04%)
303
1 months 27 days ago
19/23 (82.61%)
$36.35 (19.00%)
119
Buy
300
2 months 1 days ago
3/3 (100%)
$47.9 (25.25%)
91
Buy
286
$-20.5 (-6.69%)
185
3 months 6 days ago
15/16 (93.75%)
$25.59 (14.13%)
88
Buy
297
$-9.5 (-3.10%)
250
3 months 23 days ago
5/5 (100%)
$31.93 (16.93%)
87
